Reducción persistente de corticosteroides orales independientemente de la dosis basal, en pacientes con asma córtico-dependiente tratados con dupilumab: Estudio Liberty Asthma-Traverse

Translated title of the contribution: Persistent OCS Reduction Regardless of Starting OCS Dose in Patients With Severe, OCSDependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study

Christian Domingo, Mark Gurnell, Klaus F Rabe, Andrew Menzies-Gow, David Price, Guy Brusselle, Michael E Wechsler, Changming Xia, Michel Djandji, Rebecca Gall, Juby A. Jacob-Nara, Paul J. Rowe, Yamo Deniz, Shahid Siddiqui

Research output: Contribution to conferenceAbstractpeer-review

Translated title of the contributionPersistent OCS Reduction Regardless of Starting OCS Dose in Patients With Severe, OCSDependent Asthma Treated With Dupilumab: LIBERTY ASTHMA TRAVERSE Study
Original languageSpanish
Publication statusAccepted/In press - 2 Mar 2022
Event55 Congreso Separ - Pamplona, Spain
Duration: 2 Jun 20224 Jun 2022
Conference number: 55th
https://www.congresosepar.com/SEPAR2022

Conference

Conference55 Congreso Separ
Country/TerritorySpain
CityPamplona
Period2/06/224/06/22
Internet address

Cite this